- Home
- SCNX vs MNDO Comparison
SCNX vs MNDO Comparison
Compare SCNX & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCNX | MNDO |
|---|---|---|
| Founded | 2010 | 1995 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 18.6M |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SCNX | MNDO |
|---|---|---|
| Price | $2.93 | $0.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 50.6K | 28.4K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,831,778.00 | N/A |
| Revenue This Year | $1,009.57 | N/A |
| Revenue Next Year | $259.51 | N/A |
| P/E Ratio | ★ N/A | $8.57 |
| Revenue Growth | ★ 30.72 | N/A |
| 52 Week Low | $3.21 | $0.85 |
| 52 Week High | $106.25 | $1.29 |
Technical Indicators
Market Signals| Indicator | SCNX | MNDO |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 36.95 |
| Support Level | N/A | $0.89 |
| Resistance Level | $11.68 | $1.08 |
| Average True Range (ATR) | 8.43 | 0.04 |
| MACD | -1.26 | -0.01 |
| Stochastic Oscillator | 0.09 | 19.11 |
Price Performance
Historical ComparisonAbout SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.